Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the objective tumor response and remission rate of AIDS-related Kaposi's
sarcomas (KS) following a single dose of tin ethyl etiopurpurin (SnET2) followed by
photodynamic therapy (PDT). To determine the systemic and local toxicity, and morbidity
safety profile of SnET2-PDT.